In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Donald Addington
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Donald Addington

First Name:Donald
Last Name:Addington
Advanced Degrees:MBBS
Affiliation:University of Calgary
Street Address 1:Foothills Hospital Department of Psychiatry
Street Address 2:1403 29th Street NW
Zip/Postal Code:T2N 2T9
Email Address:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 17 January 2006]
Clinical Interests:
Research Focus:
Clinical trials
Work Sector(s):
Medical hospital
Reasearcher Bio
I have 20 years experience as a clinical researcher with interests in phenomenology, pharmacotherapy and health care services research.
Top Papers
Addington D, Addington J, Schissel B. Related Articles, Links
A depression rating scale for schizophrenics.
Schizophr Res. 1990 Jul-Aug;3(4):247-51

Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, Beauclair L
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia.

Addington D. The use of placebos in clinical trials for acute schizophrenia.
Can J Psychiatry. 1995 May;40(4):171-6. Review.
PMID: 7621385 [PubMed - indexed for MEDLINE

Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. Related Articles, Links
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Schizophr Res. 2003 May 1;61(1):19-30.
PMID: 12648732 [PubMed - indexed for MEDLINE]

Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005 Oct 1;78(1):35-43.

Addington,D.; Mckenzie,E.; Addington,J.; Patten,S.; Smith,H.; Adair,C. Performance measures for early psychosis treatment services Psychiatric Services 2005;57(12; 1570-1582

What are the top three papers (not yours) you have read recently?
1. Petersen L, Jeppesen P, Thorup A, Abel MB, Ohlenschlaeger J, Christensen TO, Krarup G, Jorgensen P, Nordentoft M: A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. Br Med J 2005; 331(7517):602
Ref ID: 3000
2. Committee on crossing the quality chasm: Adaptation for mental health and addictive disorders. Improving the quality of health care for mental and substance-use conditions: quality chasm series. 1-600. 2005. Washington DC, National Academy of Sciences. Quality Chasm Series.
Ref Type: Report
Ref ID: 2987
3. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62(9):975-983
Ref ID: 2966
If resources were not limited, what research projects would you pursue?
Intervention in pre-psychosis patients
What is your leading hypothesis?
Neurodevelopmental hypothesis

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright